NMRD — Nemaura Medical Inc.
Healthcare • Medical - Devices
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons...…
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $0.00
- Day High
- $0.00
- Day Low
- $0.00
- 52w High
- $0.00
- 52w Low
- $0.00
- Volume
- 500
- Avg Volume
- Beta
- 0.923
* TTM/most recent where available
Company
- Ticker
- NMRD
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
- CEO
- Dewan Fazlul Hoque Chowdhury
- Employees
- 36
- Website
- nemauramedical.com
Key Metrics
- Market Cap
- 8.07K
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).